Willow Biosciences Inc. (WLLW.TO)

$0.17

+0.01 (+6.25%)
Rating:
Recommendation:
-
Symbol WLLW.TO
Price $0.17
Beta 1.116
Volume Avg. 0.17M
Market Cap 21.012M
Shares () -
52 Week Range 0.155-1.15
1y Target Est -
DCF Unlevered WLLW.TO DCF ->
DCF Levered WLLW.TO LDCF ->
ROE 7.24% Neutral
ROA 7.24% Neutral
Operating Margin -
Debt / Equity 11.48% Neutral
P/E 5.67 Buy
P/B 0.77 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Trevor Anthony Peters
Healthcare
Drug Manufacturers—Specialty & Generic
Toronto Stock Exchange

Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.